2. THE LANGUAGE OF NUCLEOTIDE SEQUENCE ON
m-RNA ( GENTIC CODE ) IS TRANSLATED IN TO THE
LANGUAGE OF AMINIO ACID SEQUENCE.
3. t-RNA ( soluble RNA)
Transfer A.A from cytosol to the
ribosomal protein synthesising
machinery.
73 – 93 nucleotides in length
4. RIBOSOMES
INFRASTRUCTURE FOR THE m-RNA, t-
RNA & A.A TO INTERACT WITH EACH
OTHER FOR TRANSLATION.
80S IN EUKARYOTES & 60S IN
PROKARYOTES.
LARGER 60S (50S) SUBUNIT
SMALLER 40S (30S) SUBUNIT
7. ACTIVATION OF A.A
AMINOACYL t-RNA SYNTHETASE
A.A + t-RNA + ATP Aminoacyl t-RNA + AMP
8. ACTIVATION OF A.A
AMINOACYL t-RNA SYNTHETASE
D ARM OF tRNA RECOGNISED BY THE ENZYME
A.A + t-RNA + ATP Aminoacyl t-RNA + AMP
ENZYME IDENTIFIES THE SPECIFIC t-RNA
TRANSFERS AMINOACYL GROUP TO 3’ END
CCA
-COOH GROUP OF A.A ESTERIFIED WITH THE
3’ OH GROUP OF t-RNA.
AT LEAST 1 ENZYME FOR 1 A.A
9.
10.
11. mRNA is read in 5’ to 3’ direction
PROTEIN SYNTHESIS TAKES PLACE
FROM N-TERMINAL TO C-TERMENAL END
12. INITIATION:
Basic requirements for initiation
Ribosome
mRNA to be translated
The initiating Met-tRNA
A set of protein factors called initiation factors.
In Eukaryotes there are at least nine factors,
designated
e If to indicate eukaryotic origin.
In prokaryotes, three initiation factors are known
IF1, IF2 and IF3
13. Steps involved in Initiation:
1. Ribosomal dissociation
2. Formation of 43S pre-initiation complex
3. Formation of 48S initiation complex
4. Formation of 80S initiation complex
14. Ribosomal dissociation:
eIF3 and eIF1 A binds to 40S subunit and
prevents the reassociation with 60S – causing
ribosomal subunit dissociation.
15. 2. Formation of 43S pre-initiation complex
GTP + eIF2
This complex binds to met-tRNA-I
This GTP-eIF2-tRNA-I complex binds to the 40S
ribosomal subunit to form 43S pre-initiation
complex.
16. 3. Formation of 48S initiation complex
Binding of m-RNA to 43S pre-initiation complex forms 48S
initiation complex.
5’ end of m-RNA contains CAP which helps in binding of m-
RNA to 43S pre-initiation complex.
The association of mRNA with 43S initiation complex
requires:
CAP binding protein, eIF4, ATP
KOZAK CONSENSUS (EUKARYOTES) on mRNA
facilitates binding of mRNA to pre-initiation complex
SHINE DALGARNO SEQUENCE on mRNA facilitates
binding of mRNA to pre-initiation complex
17. 4. FORMATION OF 80S RIBOSOME
ASSEMBLY
48S INITIATION COMPLEX + 60S
RIBOSOME.
+ e-IF2 + e-IF5.
e-IF 5 HAS GTPase ACTIVITY.
GTP BOUND IN STEP 1 HYDROLYSED FOR
ENERGY.
ALL INITIATION FACTORS NOW
RELEASED.
NEXT STAGE IS
ELONGATION.
20. P & A SITES
RIBOSOME CONTAINS 2 RECEPTOR SITES
FOR t-RNA MOLECULES
P (PEPTIDYL) SITE
A (AMINOACYL) SITE
Met-t-RNA OCCUPIES P SITE.
ALL OTHER t-RNAs OCCUPY A SITE
t-RNA BINDS WITH RIBOSOME THROUGH
THE PSEUDOURIDINE ARM
ANTICODON OF t-RNA & CODON ON m-RNA
BIND
A SITE IS FREE NOW.
21.
22.
23.
24. ELONGATION:
BINDING OF NEW AMINOACYL t-RNA
CODON IN m-RNA DETERMINES THE INCOMING
A.A
EF 1 & GTP REQD.
PEPTIDE BOND FORMATION:
α-NH2 GROUP OF INCOMING A.A IN A SITE
FORMS PEPTIDE BOND WITH COOH GROUP OF
A.A IN P SITE.
ENZYME IS PEPTIDYL TRANSFERASE
NO NEED FOR ENERGY AS A.A IS ACTIVATED.
25. TRANSLOCATION:
WHEN PEPTIDE BOND FORMED Met
FROM P SITE SHIFTED TO A SITE.
t RNA IS RELEASED FROM P SITE, NOW P
SITE FREE
RIBOSOME MOVES FORWARD BY 1 CODON
PEPTIDYL t-RNA TRANSLOCATED TO P
SITE.NOW A SITE EMPTY
NEW AMINOACYL t-RNA WILL COME ONLY
TO A SITE.
STEP REQUIRES EF 2 AND ENERGY FROM
GTP.
NEW AMINOACYL t-RNA CAN COME IN
ELONGATION CONTINUES….
27. ENERGY REQUIREMENTS:
ACTIVATION OF A.A 2 ATP
FOR PRE-INITIATION COMPLEX 1 GTP
FOR INITIATION COMPLEX 1 ATP
BINDING OF AMINOACYL t-RNA 1 GTP
TANSLOCATION PROCESS 1 GTP
28. TERMINATION;
SUCCESSIVE ADDITIONS OF A.A
TERMINATION CODONS REACHED.
NO t-RNA CORRESPONDING TO
TERMINATION CODON
A SITE REMAINS FREE
RELEASING FACTOR ENTERS A SITE
RELEASES THE PEPTIDE CHAIN WITH
HYDROLYSIS OF GTP.
RIBOSOME DISSOCIATES INTO 60 AND
40S
SUBUNITS.
32. PROTEIN TARGETTING:
PROTEINS FOR EXTERNAL SECRETION:
SYNTHESISED ON RER
SIGNAL PEPTIDE (LEADER sequence)
THRO ER, GOLGI
REACHES CORRECT DESTINATION.
INTERNAL PROTEINS:
LACK SIGNAL PEPTIDE
FREE RIBOSOMES
DO NOT ENTER ER. ARE AVAILLABLE IN
CYTOPLASM.